JP Morgan Chase’s Cellyan Biotechnology HKPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$12 Buy
+6
New +$38 ﹤0.01% 8037

Other funds holding HKPD

JP Morgan Chase's HKPD Position: Q3 2026 in Review

JP Morgan Chase opened a new position in Cellyan Biotechnology (HKPD) in Q3 2026: 6 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #8037 among its holdings.

9 funds tracked by Wall St. Rank hold HKPD as of Q3 2026.

  • JP Morgan Chase held 6 shares of Cellyan Biotechnology worth $12 as of Q3 2026.
  • Cellyan Biotechnology was a new JP Morgan Chase position in Q3 2026.
  • Cellyan Biotechnology made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #8037 holding.
  • 9 funds tracked by Wall St. Rank held Cellyan Biotechnology as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.